List of Tables
Table 1. Gaucher’s Disease Treatment Market Trends
Table 2. Gaucher’s Disease Treatment Market Drivers & Opportunity
Table 3. Gaucher’s Disease Treatment Market Challenges
Table 4. Gaucher’s Disease Treatment Market Restraints
Table 5. Global Gaucher’s Disease Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Gaucher’s Disease Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Gaucher’s Disease Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Gaucher’s Disease Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Gaucher’s Disease Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Gaucher’s Disease Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Gaucher’s Disease Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Gaucher’s Disease Treatment
Table 13. Global Gaucher’s Disease Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gaucher’s Disease Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Gaucher’s Disease Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Gaucher’s Disease Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Gaucher’s Disease Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Gaucher’s Disease Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Gaucher’s Disease Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Gaucher’s Disease Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Gaucher’s Disease Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Gaucher’s Disease Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Gaucher’s Disease Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Gaucher’s Disease Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Gaucher’s Disease Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Gaucher’s Disease Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Gaucher’s Disease Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Gaucher’s Disease Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Gaucher’s Disease Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Gaucher’s Disease Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Gaucher’s Disease Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Gaucher’s Disease Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Gaucher’s Disease Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Gaucher’s Disease Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Gaucher’s Disease Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Gaucher’s Disease Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Gaucher’s Disease Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Gaucher’s Disease Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Gaucher’s Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Gaucher’s Disease Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Gaucher’s Disease Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Gaucher’s Disease Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Gaucher’s Disease Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Gaucher’s Disease Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Gaucher’s Disease Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Gaucher’s Disease Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Gaucher’s Disease Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Gaucher’s Disease Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Gaucher’s Disease Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Gaucher’s Disease Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Gaucher’s Disease Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Gaucher’s Disease Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Gaucher’s Disease Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Gaucher’s Disease Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Gaucher’s Disease Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. Amicus Therapeutics, Inc. Company Information
Table 58. Amicus Therapeutics, Inc. Introduction and Business Overview
Table 59. Amicus Therapeutics, Inc. Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Amicus Therapeutics, Inc. Gaucher’s Disease Treatment Product Offerings
Table 61. Amicus Therapeutics, Inc. Recent Development
Table 62. Novartis AG Company Information
Table 63. Novartis AG Introduction and Business Overview
Table 64. Novartis AG Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Novartis AG Gaucher’s Disease Treatment Product Offerings
Table 66. Novartis AG Recent Development
Table 67. Shire plc Company Information
Table 68. Shire plc Introduction and Business Overview
Table 69. Shire plc Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Shire plc Gaucher’s Disease Treatment Product Offerings
Table 71. Shire plc Recent Development
Table 72. Actelion Pharmaceuticals Ltd. Company Information
Table 73. Actelion Pharmaceuticals Ltd. Introduction and Business Overview
Table 74. Actelion Pharmaceuticals Ltd. Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Actelion Pharmaceuticals Ltd. Gaucher’s Disease Treatment Product Offerings
Table 76. Actelion Pharmaceuticals Ltd. Recent Development
Table 77. Protalix Bio Therapeutics Inc. Company Information
Table 78. Protalix Bio Therapeutics Inc. Introduction and Business Overview
Table 79. Protalix Bio Therapeutics Inc. Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Protalix Bio Therapeutics Inc. Gaucher’s Disease Treatment Product Offerings
Table 81. Protalix Bio Therapeutics Inc. Recent Development
Table 82. Johnson & Johnson Company Information
Table 83. Johnson & Johnson Introduction and Business Overview
Table 84. Johnson & Johnson Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Johnson & Johnson Gaucher’s Disease Treatment Product Offerings
Table 86. Johnson & Johnson Recent Development
Table 87. Takeda Pharmaceutical Company Limited Company Information
Table 88. Takeda Pharmaceutical Company Limited Introduction and Business Overview
Table 89. Takeda Pharmaceutical Company Limited Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Takeda Pharmaceutical Company Limited Gaucher’s Disease Treatment Product Offerings
Table 91. Takeda Pharmaceutical Company Limited Recent Development
Table 92. Abbott Laboratories Company Information
Table 93. Abbott Laboratories Introduction and Business Overview
Table 94. Abbott Laboratories Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Abbott Laboratories Gaucher’s Disease Treatment Product Offerings
Table 96. Abbott Laboratories Recent Development
Table 97. Aptalis Pharma Inc. Company Information
Table 98. Aptalis Pharma Inc. Introduction and Business Overview
Table 99. Aptalis Pharma Inc. Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Aptalis Pharma Inc. Gaucher’s Disease Treatment Product Offerings
Table 101. Aptalis Pharma Inc. Recent Development
Table 102. GSK Plc Company Information
Table 103. GSK Plc Introduction and Business Overview
Table 104. GSK Plc Gaucher’s Disease Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. GSK Plc Gaucher’s Disease Treatment Product Offerings
Table 106. GSK Plc Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Gaucher’s Disease Treatment Downstream Customers
Table 110. Gaucher’s Disease Treatment Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Gaucher’s Disease Treatment Product Picture
Figure 2. Global Gaucher’s Disease Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Gaucher’s Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Gaucher’s Disease Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Gaucher’s Disease Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Gaucher’s Disease Treatment Report Years Considered
Figure 7. Global Gaucher’s Disease Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Gaucher’s Disease Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Gaucher’s Disease Treatment Revenue in 2023
Figure 10. Gaucher’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Enzyme Replacement Therapy Picture
Figure 12. Substrate Reduction Therapy Picture
Figure 13. Splenectomy Picture
Figure 14. Orthopaedic Surgery Picture
Figure 15. Gene Therapy Picture
Figure 16. Others Picture
Figure 17. Global Gaucher’s Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Gaucher’s Disease Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 19. Global Gaucher’s Disease Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 20. Global Gaucher’s Disease Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 21. Global Gaucher’s Disease Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 22. Product Picture of Clinic
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Others
Figure 25. Global Gaucher’s Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Gaucher’s Disease Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 27. Global Gaucher’s Disease Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 28. Global Gaucher’s Disease Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 29. Global Gaucher’s Disease Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 30. North America Gaucher’s Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Gaucher’s Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 32. Europe Gaucher’s Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Gaucher’s Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 34. Asia Pacific Gaucher’s Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Gaucher’s Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 36. South America Gaucher’s Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 37. South America Gaucher’s Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Gaucher’s Disease Treatment Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Gaucher’s Disease Treatment Sales Value by Country (%), 2023 VS 2030
Figure 40. Key Countries/Regions Gaucher’s Disease Treatment Sales Value (%), (2019-2030)
Figure 41. Key Countries/Regions Gaucher’s Disease Treatment Sales Volume (%), (2019-2030)
Figure 42. United States Gaucher’s Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. United States Gaucher’s Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. United States Gaucher’s Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. Europe Gaucher’s Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. Europe Gaucher’s Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. Europe Gaucher’s Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. China Gaucher’s Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. China Gaucher’s Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. China Gaucher’s Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. Japan Gaucher’s Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. Japan Gaucher’s Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. Japan Gaucher’s Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. South Korea Gaucher’s Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 55. South Korea Gaucher’s Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 56. South Korea Gaucher’s Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 57. Southeast Asia Gaucher’s Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 58. Southeast Asia Gaucher’s Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 59. Southeast Asia Gaucher’s Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 60. India Gaucher’s Disease Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 61. India Gaucher’s Disease Treatment Sales Value by Type (%), 2023 VS 2030
Figure 62. India Gaucher’s Disease Treatment Sales Value by Application (%), 2023 VS 2030
Figure 63. Gaucher’s Disease Treatment Industrial Chain
Figure 64. Gaucher’s Disease Treatment Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
